Stock News - Silexion Therapeutics Corp $SLXNW
Latest Stock News for $SLXNW
Silexion Therapeutics Corp Removes Director Ilan Levin from Board Effective Immediately
Expected Stock impact: Slightly Negative
2026-03-25 20:32:15
Silexion Therapeutics Receives Approval for Phase 2/3 Clinical Trial of SIL204 in Pancreatic Cancer
Expected Stock impact: Very Positive
2026-03-24 13:10:13
Silexion Therapeutics Corp Fails to Approve Share Capital Increase at Reconvened Meeting
Expected Stock impact: Slightly Negative
2026-03-23 20:34:30
